Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05547048 · ClinicalTrials.gov registry record · Phase 4
Integrated e-Health (Electronic Health) for HIV and Substance Use Disorders in Justice Involved Women
A Phase 4 study of HIV and Opioid Use Disorder, sponsored by Yale University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 250
- Enrollment target
- 2
- Study locations
NCT05547048: Recruiting Phase 4 study of HIV and Opioid Use Disorder, sponsored by Yale University.
NCT05547048 is a Phase 4 study of HIV and Opioid Use Disorder that is actively recruiting participants, run by Yale University. The registered enrollment target is 250 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (43% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05547048, a Phase 4 study of HIV and Opioid Use Disorder, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 250 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this 2-site (CT, AL) study is to test innovative interventions to reduce stigma and improve the pre-exposure prophylaxis (PrEP) and opioid use disorder (OUD) care continua in women involved in the criminal justice system (WICJ). This study evaluates a newly validated PrEP decision aid and eHealth for integrated PrEP and MOUD compared to a decision aid-only for WICJ with OUD.
Primary Outcome
PrEP in initiation will be determined using dates of prescription and pharmacy fill and medication type (brand/generic)
Conditions Studied
Interventions
- BEHAVIORAL Decision Aid
- COMBINATION_PRODUCT Athena strategy
Study Locations (2)
Alabama
- University of Alabama in Birmingham - Birmingham
Connecticut
- Yale University - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2023-07-25 |
| Est. Completion | 2027-04-01 |
| Phase | Phase 4 |
What NCT05547048 shows while recruiting
NCT05547048 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 439-participant average among 303 other HIV trials with a reported enrollment target (43% lower).
The record links to 3 conditions, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Decision Aid is the first listed.
NCT05547048 reports a single indexed study location in Alabama, Connecticut.
Frequently Asked Questions
What is clinical trial NCT05547048 about?
NCT05547048 is a clinical study titled "Integrated e-Health (Electronic Health) for HIV and Substance Use Disorders in Justice Involved Women". The purpose of this 2-site (CT, AL) study is to test innovative interventions to reduce stigma and improve the pre-exposure prophylaxis (PrEP) and opioid use disorder (OUD) care continua in women involved in the criminal justice system (WICJ). This study evaluates a newly validated PrEP decision ai...
What is the current status of trial NCT05547048?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 250 participants. The study started on 2023-07-25. Estimated completion is 2027-04-01.
What conditions does trial NCT05547048 study?
This clinical trial studies the following conditions: HIV, Opioid Use Disorder, eHealth.
What interventions are being tested in trial NCT05547048?
The interventions under investigation include: Decision Aid (BEHAVIORAL), Athena strategy (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT05547048?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05547048 being conducted?
This trial has 2 study locations across Alabama, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05547048's enrollment target sits among peer trials
250 87th of 303 higher than 216 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Assessment of Metformin for Restoration of Immune Homeostasis in HIV+ and HIV- Individuals With a History of Injection Drug Use
RECRUITING · Phase 4
-
Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs
RECRUITING · Phase 4
-
Implementation and Deliver of Lenacapavir for PrEP in a Community Pharmacy Setting
RECRUITING · Phase 4
-
Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP
RECRUITING · Phase 4
-
Immediate Initiation of Antiretroviral Therapy During "Hyperacute" HIV Infection
ACTIVE NOT RECRUITING · Phase 4
-
Emtricitabine/Tenofovir Alafenamide Switch Study for Transgender Individuals for HIV Pre-exposure Prophylaxis
ACTIVE NOT RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI